The pervasive involvement of AR signaling in the later stages of PCa presents a conundrum as well, because it affects an entire massive transcriptional program that is further affected by additional alterations in tumor suppressors, transcription factors, chromatin remodeling enzymes and, almost universally, developmental factors. The gene discussed is AR; the disease is posterior cortical atrophy.